ifosfamide has been researched along with Cancer of Mediastinum in 60 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The results however, did not show expected treatment efficacy and we raise the idea of paclitaxel dosage relevance in TIP." | 2.71 | Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study. ( Hlavatá, Z; Koza, I; Mardiak, J; Mego, M; Obertová, J; Recková, M; Sálek, T; Sycová-Milá, Z, 2005) |
| "Ifosfamide was given at the dosage of 2." | 2.67 | Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results. ( Faustini, M; Gianni, L; Nicolai, N; Piva, L; Pizzocaro, G; Salvioni, R, 1992) |
| "Brain metastases are rare in the natural history of Wilms tumor." | 2.41 | Brain metastases in Wilms' tumor: case report and literature review. ( Grimard, L; Halton, JM; Hsu, E; MacRae, R; Nizalik, E, 2002) |
| "The treatment of primary mediastinal germ cell tumors with cisplatin-based chemotherapy followed by surgery is an established practice; however, the prognosis has remained poor." | 1.40 | Outcomes of combined modality therapy for patients with stage III or IV mediastinal malignant germ cell tumors. ( Kuwano, H; Murakawa, T; Murayama, T; Nagayama, K; Nakajima, J; Sano, A; Tsuchiya, T; Yoshida, Y, 2014) |
| "Mediastinal embryonal carcinoma is rare, and the life prognosis of this disease is assumed to be relatively short." | 1.40 | A case of mediastinal embryonal carcinoma successfully treated by integrative therapy. ( Hirasawa, A; Kamiya, M; Kawanami, K; Sato, K; Takahashi, E; Takeuchi, M; Wakao, N, 2014) |
| "Mediastinal angiosarcoma is a rare intrathoracic tumour and the therapeutic approach remains poorly codified." | 1.38 | [A case of mediastinal angiosarcoma]. ( Aubert, M; Coudurier, M; Deroux, A; Destors, M; Girard, N; Lantuejoul, S; Moro-Sibilot, D, 2012) |
| "Angiosarcoma is a rare neoplasm, accounting for only 1%-2% of all sarcomas." | 1.37 | Radically resected epithelioid angiosarcoma that originated in the mediastinum. ( Nakai, R; Tanaka, Y; Tane, S; Tauchi, S; Uchino, K; Yoshimura, M, 2011) |
| "Histology of the primary germ cell tumor was pure seminoma in 14 (27%), and non-seminoma in 30 (59%)." | 1.36 | [Result of treatment for advanced germ cell tumor in the last decade]. ( Fukuda, H; Fukui, N; Higashi, Y; Hyochi, N; Ichiyanagi, N; Inoue, M; Ishioka, J; Kageyama, Y; Numao, N; Saito, K; Tanak, M, 2010) |
| "Primary mediastinal nonseminomatous germ cell tumors (NSGCT) have a worse prognosis than gonadal germ cell tumors (GCTs)." | 1.35 | Metastatic malignant teratoma arising from mediastinal nonseminomatous germ cell tumor: a case report. ( Carmichael, M; Collen, J; Wroblewski, T, 2008) |
| "One patient developed a secondary acute myeloid leukemia (s-AML) involving a chromosomal translocation t(11;19)(q23;p13." | 1.33 | Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer. ( Boehlke, I; Bokemeyer, C; Hartmann, JT; Kanz, L; Kollmannsberger, C; Kuczyk, M; Metzner, B; Schleicher, J; Schleucher, N; Wierecky, J, 2005) |
| "Of the 13 cases, 5 were Hodgkin's disease (HD), and 8 were non-Hodgkin's lymphoma (NHL)." | 1.33 | [Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma]. ( Ling, JY; Sun, XF; Wang, ZH; Xia, Y; Zhen, ZJ, 2006) |
| "Although FDC sarcoma is considered a low-grade tumor, the tumor in the present case not only developed at an unusual location with bone metastasis but also involved bone marrow." | 1.33 | Mediastinal follicular dendritic cell sarcoma involving bone marrow: a case report and review of the literature. ( Admirand, JH; Bueso-Ramos, CE; Ford, RJ; Jiang, L; Moran, C, 2006) |
| "Necrosis was found in 22 (38%) of 57 patients, mature teratoma with or without necrosis was found in nine (16%) of 57 patients, and viable cancer with or without additional necrosis or mature teratoma was found in 26 (46%) of 57 patients." | 1.32 | Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer. ( Beyer, J; Bokemeyer, C; Braun, T; Hartmann, JT; Hartmann, M; Pottek, T; Rachud, B; Rick, O; Schirren, J; Siegert, W; Weinknecht, S; Weissbach, L, 2004) |
| "These were neuroepithelioma, lymphoma, desmoplastic small-cell tumor, melanoma, and clear-cell sarcoma." | 1.29 | Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site. ( Bosl, GJ; Chaganti, RS; Mazumdar, M; Motzer, RJ; Reuter, VE; Rodriguez, E, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.33) | 18.7374 |
| 1990's | 14 (23.33) | 18.2507 |
| 2000's | 20 (33.33) | 29.6817 |
| 2010's | 22 (36.67) | 24.3611 |
| 2020's | 2 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, D | 1 |
| Chen, M | 1 |
| Wang, B | 1 |
| Gou, Y | 1 |
| Darif, K | 1 |
| Benbrahim, Z | 1 |
| Acharfi, N | 1 |
| Khacha, A | 1 |
| Maaroufi, M | 1 |
| Amaadour, L | 1 |
| Oualla, K | 1 |
| Arifi, S | 1 |
| Mellas, N | 1 |
| Seno, N | 1 |
| Fukushima, T | 1 |
| Gomi, D | 1 |
| Kobayashi, T | 1 |
| Sekiguchi, N | 1 |
| Matsushita, H | 1 |
| Ozawa, T | 1 |
| Tsukahara, Y | 1 |
| Mamiya, K | 1 |
| Koizumi, T | 1 |
| Sano, K | 1 |
| Kuwano, H | 1 |
| Tsuchiya, T | 1 |
| Murayama, T | 1 |
| Sano, A | 1 |
| Nagayama, K | 1 |
| Yoshida, Y | 1 |
| Murakawa, T | 1 |
| Nakajima, J | 1 |
| Eroglu, C | 1 |
| Kaynar, L | 1 |
| Orhan, O | 1 |
| Keklik, M | 1 |
| Sahin, C | 1 |
| Yildiz, OG | 1 |
| Mentes, S | 1 |
| Kurnaz, F | 1 |
| Aslan, D | 1 |
| Sivgin, S | 1 |
| Soyuer, S | 1 |
| Eser, B | 1 |
| Cetin, M | 1 |
| Unal, A | 1 |
| Al-Hader, AA | 1 |
| Jain, A | 1 |
| Al-Nasrallah, N | 1 |
| Einhorn, LH | 6 |
| Hernández-Marqués, C | 1 |
| Lassaletta, A | 1 |
| Cormenzana, M | 1 |
| García-Esparza, E | 1 |
| Madero-López, L | 1 |
| Tanaka, H | 1 |
| Yuasa, T | 1 |
| Fujii, Y | 1 |
| Sakura, M | 1 |
| Urakami, S | 1 |
| Yamamoto, S | 1 |
| Masuda, H | 1 |
| Fukui, I | 1 |
| Yonese, J | 1 |
| Kawanami, K | 1 |
| Wakao, N | 1 |
| Kamiya, M | 1 |
| Takeuchi, M | 1 |
| Hirasawa, A | 1 |
| Takahashi, E | 1 |
| Sato, K | 1 |
| Fizazi, K | 1 |
| Pagliaro, L | 2 |
| Laplanche, A | 1 |
| Fléchon, A | 2 |
| Mardiak, J | 2 |
| Geoffrois, L | 2 |
| Kerbrat, P | 1 |
| Chevreau, C | 1 |
| Delva, R | 1 |
| Rolland, F | 1 |
| Theodore, C | 1 |
| Roubaud, G | 1 |
| Gravis, G | 1 |
| Eymard, JC | 1 |
| Malhaire, JP | 1 |
| Linassier, C | 1 |
| Habibian, M | 1 |
| Martin, AL | 1 |
| Journeau, F | 1 |
| Reckova, M | 2 |
| Logothetis, C | 1 |
| Culine, S | 1 |
| Joly, C | 1 |
| Deblock, M | 1 |
| Desandes, E | 1 |
| Nieto, Y | 1 |
| Tu, SM | 1 |
| Bassett, R | 1 |
| Jones, RB | 1 |
| Gulbis, AM | 1 |
| Tannir, N | 1 |
| Kingham, A | 1 |
| Ledesma, C | 1 |
| Margolin, K | 2 |
| Holmberg, L | 1 |
| Champlin, R | 1 |
| Gallo, K | 1 |
| Brickman, A | 1 |
| Warren, WH | 1 |
| Gattuso, P | 1 |
| Seder, CW | 1 |
| Lopes, LF | 1 |
| Macedo, CR | 1 |
| Aguiar, Sdos S | 1 |
| Barreto, JH | 1 |
| Martins, GE | 1 |
| Sonaglio, V | 1 |
| Milone, M | 1 |
| Lima, ER | 1 |
| Almeida, MT | 1 |
| Lopes, PM | 1 |
| Watanabe, FM | 1 |
| D'Andrea, ML | 1 |
| Pianovski, MA | 1 |
| Melaragno, R | 1 |
| Vianna, SM | 1 |
| Moreira, ME | 1 |
| Bruniera, P | 1 |
| de Oliveira, CZ | 1 |
| Ranganath, P | 1 |
| Kesler, KA | 1 |
| Zschäbitz, S | 1 |
| Lasitschka, F | 1 |
| Hadaschik, B | 1 |
| Hofheinz, RD | 1 |
| Jentsch-Ullrich, K | 1 |
| Grüner, M | 1 |
| Jäger, D | 1 |
| Grüllich, C | 1 |
| Gatcombe, HG | 1 |
| Olson, TA | 1 |
| Esiashvili, N | 1 |
| Ishioka, J | 1 |
| Kageyama, Y | 1 |
| Inoue, M | 1 |
| Fukui, N | 1 |
| Numao, N | 1 |
| Saito, K | 2 |
| Ichiyanagi, N | 1 |
| Tanak, M | 1 |
| Hyochi, N | 1 |
| Fukuda, H | 1 |
| Higashi, Y | 1 |
| Daugaard, G | 1 |
| Skoneczna, I | 1 |
| Aass, N | 1 |
| De Wit, R | 1 |
| De Santis, M | 1 |
| Dumez, H | 2 |
| Marreaud, S | 1 |
| Collette, L | 1 |
| Lluch, JRG | 1 |
| Bokemeyer, C | 6 |
| Schmoll, HJ | 4 |
| Braquet, P | 1 |
| Chapelle, A | 1 |
| Jorgensen, C | 1 |
| Pers, YM | 1 |
| Tane, S | 1 |
| Tanaka, Y | 1 |
| Tauchi, S | 1 |
| Uchino, K | 1 |
| Nakai, R | 1 |
| Yoshimura, M | 1 |
| Onesti, E | 1 |
| Fabi, A | 1 |
| Mingoia, M | 1 |
| Savarese, A | 1 |
| Anelli, V | 1 |
| Koudriavtseva, T | 1 |
| Deroux, A | 1 |
| Destors, M | 1 |
| Coudurier, M | 1 |
| Lantuejoul, S | 1 |
| Aubert, M | 1 |
| Girard, N | 1 |
| Moro-Sibilot, D | 1 |
| Jarfaut, A | 1 |
| Santucci, R | 1 |
| Levêque, D | 1 |
| Herbrecht, R | 1 |
| Schleucher, N | 2 |
| Metzner, B | 3 |
| Thomas, M | 1 |
| Rick, O | 7 |
| Kollmannsberger, C | 2 |
| Boehlke, I | 2 |
| Kanz, L | 3 |
| Hartmann, JT | 4 |
| Christodoulou, J | 1 |
| Schoch, C | 1 |
| Schnittger, S | 1 |
| Haferlach, T | 1 |
| Van der Mieren, G | 1 |
| Willems, S | 1 |
| Sciot, R | 1 |
| Van Oosterom, A | 1 |
| Flameng, W | 1 |
| Herijgers, P | 1 |
| Weinknecht, S | 2 |
| Schirren, J | 1 |
| Pottek, T | 1 |
| Braun, T | 1 |
| Rachud, B | 1 |
| Weissbach, L | 1 |
| Hartmann, M | 1 |
| Siegert, W | 8 |
| Beyer, J | 8 |
| Wierecky, J | 1 |
| Kuczyk, M | 1 |
| Schleicher, J | 3 |
| Nath, SV | 1 |
| Seymour, JF | 1 |
| Kawabe, M | 1 |
| Sasaki, K | 1 |
| Shinoda, T | 1 |
| Tanabe, S | 1 |
| Handa, M | 1 |
| Hirai, S | 1 |
| Yamada, N | 1 |
| Uesaka, T | 1 |
| Morioka, K | 1 |
| Ihaya, A | 1 |
| Tanaka, K | 1 |
| Imamura, Y | 1 |
| Sálek, T | 1 |
| Sycová-Milá, Z | 1 |
| Obertová, J | 1 |
| Hlavatá, Z | 1 |
| Mego, M | 1 |
| Koza, I | 1 |
| Zhen, ZJ | 1 |
| Sun, XF | 1 |
| Xia, Y | 1 |
| Wang, ZH | 1 |
| Ling, JY | 1 |
| Bedano, PM | 1 |
| Bonnin, J | 1 |
| Hiraki, A | 1 |
| Murakami, T | 1 |
| Aoe, K | 1 |
| Matsuda, E | 1 |
| Maeda, T | 1 |
| Uemori, Y | 1 |
| Ueoka, H | 1 |
| Banna, GL | 1 |
| De Giorgi, U | 1 |
| Ferrari, B | 1 |
| Castagna, L | 1 |
| Alloisio, M | 1 |
| Marangolo, M | 1 |
| Rosti, G | 1 |
| Santoro, A | 1 |
| Jiang, L | 1 |
| Admirand, JH | 1 |
| Moran, C | 1 |
| Ford, RJ | 1 |
| Bueso-Ramos, CE | 1 |
| Tanigawa, M | 1 |
| Ishiga, T | 1 |
| Ichioka, M | 1 |
| Zhou, JF | 1 |
| Bai, CM | 1 |
| Yang, D | 1 |
| Chen, SC | 1 |
| Chandra, P | 1 |
| Schmidt, RM | 1 |
| Madan, P | 1 |
| Topkara, VK | 1 |
| Collen, J | 1 |
| Carmichael, M | 1 |
| Wroblewski, T | 1 |
| Valdivieso, M | 1 |
| Cabanillas, F | 1 |
| Keating, M | 1 |
| Barkley, HT | 1 |
| Murphy, WK | 1 |
| Burgess, MA | 1 |
| Frazier, H | 1 |
| Chen, T | 1 |
| Bodey, GP | 1 |
| Vicente, P | 1 |
| Garciá del Muro, X | 1 |
| Cardenal, F | 1 |
| Motzer, RJ | 1 |
| Rodriguez, E | 1 |
| Reuter, VE | 1 |
| Bosl, GJ | 1 |
| Mazumdar, M | 1 |
| Chaganti, RS | 1 |
| Strohscheer, I | 1 |
| Baurmann, H | 1 |
| Oettle, H | 1 |
| Zingsem, J | 1 |
| Zimmermann, R | 1 |
| Huhn, D | 3 |
| Gururangan, S | 1 |
| Bowman, LC | 1 |
| Parham, DM | 1 |
| Wilimas, JA | 1 |
| Rao, B | 1 |
| Pratt, CB | 1 |
| Douglass, EC | 1 |
| Soslow, RA | 1 |
| Davis, RE | 1 |
| Warnke, RA | 1 |
| Cleary, ML | 1 |
| Kamel, OW | 1 |
| Doroshow, JH | 1 |
| Ahn, C | 1 |
| Hamasaki, V | 1 |
| Leong, L | 1 |
| Morgan, R | 1 |
| Raschko, J | 1 |
| Shibata, S | 1 |
| Somlo, G | 1 |
| Tetef, M | 1 |
| Kingreen, D | 4 |
| Krause, M | 1 |
| Schwaner, I | 1 |
| Schwella, N | 3 |
| Lenz, K | 1 |
| Krusch, A | 1 |
| Kirsch, A | 1 |
| Biron, P | 1 |
| Philip, I | 1 |
| Blay, JY | 1 |
| Droz, JP | 1 |
| Ganjoo, KN | 1 |
| Chan, RJ | 1 |
| Sharma, M | 1 |
| Neureither, S | 1 |
| Casper, J | 1 |
| Wandt, H | 1 |
| Hartmann, F | 1 |
| Derigs, G | 1 |
| Gerl, A | 1 |
| Berdel, WE | 1 |
| MacRae, R | 1 |
| Grimard, L | 1 |
| Hsu, E | 1 |
| Nizalik, E | 1 |
| Halton, JM | 1 |
| Pizzocaro, G | 1 |
| Salvioni, R | 1 |
| Piva, L | 1 |
| Faustini, M | 1 |
| Nicolai, N | 1 |
| Gianni, L | 1 |
| Broun, ER | 1 |
| Nichols, CR | 1 |
| Tricot, GJ | 1 |
| Loehrer, PJ | 1 |
| Williams, SD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Risk-Adapted Strategy of the Use of Dose-Dense Chemotherapy in Patients With Poor-Prognosis Disseminated Non-Seminomatous Germ Cell Tumors[NCT00104676] | Phase 3 | 263 participants (Actual) | Interventional | 2003-11-26 | Active, not recruiting | ||
| High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors[NCT00936936] | Phase 2 | 64 participants (Actual) | Interventional | 2009-06-02 | Active, not recruiting | ||
| A Randomized Phase III Study of Sequential High-Dose Cisplatinum/Etoposide/Ifosfamide Plus Stem Cell Support Versus BEP in Patients With Poor Prognosis Germ Cell Cancer[NCT00003941] | Phase 3 | 222 participants (Anticipated) | Interventional | 1999-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
To evaluated the overall survival in both groups in participants presenting fast and slow decrease in serum levels of tumor markers. The median overall survival was defined as the median percentage of participants alive after 1 course of treatment. (NCT00104676)
Timeframe: 3 years from randomization
| Intervention | percentage of participants (Number) |
|---|---|
| Arm I | 65 |
| Arm II | 73 |
Primary objective is to compare the progression-free survival of participants after 1 cycle of treatment, treated randomly by 3 additional cycles of BEP (Arm I) or by T-BEP-Oxaliplatin/cisplatin-ifosfamide-Bleomycin (Arm II). The median progression-free survival rate was defined as the median percentage of participants alive without disease progression after 1 course of treatment. (NCT00104676)
Timeframe: 3 years from randomization
| Intervention | percentage of participants (Number) |
|---|---|
| Arm I | 48 |
| Arm II | 59 |
2 reviews available for ifosfamide and Cancer of Mediastinum
| Article | Year |
|---|---|
Leptomeningeal carcinomatosis in aggressive germ non-seminoma testicular tumor: a case report and review of literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Fatal O | 2012 |
Brain metastases in Wilms' tumor: case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Combined Modality Ther | 2002 |
11 trials available for ifosfamide and Cancer of Mediastinum
| Article | Year |
|---|---|
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Topics: Adolescent; Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomark | 2014 |
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EO
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, T | 2011 |
First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease | 2003 |
Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Germinoma; Humans; Ifosfamide; Mal | 2005 |
Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Thera | 2006 |
High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etopo | 1994 |
Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide | 1997 |
Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bo | 1997 |
High-dose chemotherapy for salvage treatment of germ cell tumors: Charité, Virchow Klinikum, Berlin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; D | 1998 |
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free S | 2001 |
Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relation | 1992 |
47 other studies available for ifosfamide and Cancer of Mediastinum
| Article | Year |
|---|---|
Mediastinal desmoplastic small round cell tumor.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Desmoplast | 2020 |
A primary mediastinal germ cell tumor of yolk sac type: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chest Pain; Combined Modality Therapy; Endod | 2021 |
Successful treatment with doxorubicin and ifosfamide for mediastinal malignant peripheral nerve sheath tumor with loss of H3K27me3 expression.
Topics: Antineoplastic Combined Chemotherapy Protocols; Down-Regulation; Doxorubicin; Female; Gene Expressio | 2017 |
Outcomes of combined modality therapy for patients with stage III or IV mediastinal malignant germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined | 2014 |
Contribution of involved-field radiotherapy to survival in patients with relapsed or refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carmustin | 2015 |
Metastatic malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): results with PNET-based chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin | 2015 |
All children with malignant rhabdoid tumors should be treated initially with intensive chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubic | 2015 |
First-line combination chemotherapy with cisplatin, etoposide and ifosfamide for the treatment of disseminated germ cell cancer: re-evaluation in the granulocyte colony-stimulating factor era.
Topics: Adult; Antineoplastic Agents; Cisplatin; Disease-Free Survival; Drug Therapy, Combination; Etoposide | 2013 |
A case of mediastinal embryonal carcinoma successfully treated by integrative therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Back Pain; Biopsy; Carcinoma, Embryonal; | 2014 |
[Primary mediastinal germs cells tumors: a twenty years experience in a comprehensive cancer center].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cancer Care Facilities; Cisplatin; | 2014 |
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; C | 2015 |
Unresectable Middle Mediastinal Biphasic Pulmonary Blastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Etoposide; H | 2015 |
Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Child; Cisplatin; Disease-Free Su | 2016 |
Perioperative Morbidity and Mortality Associated With Bleomycin in Primary Mediastinal Nonseminomatous Germ Cell Tumor.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant | 2016 |
Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemothera | 2017 |
Metastatic primary angiosarcoma of the breast in a pediatric patient with a complete response to systemic chemotherapy and definitive radiation therapy: case report and review of the literature.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combin | 2010 |
[Result of treatment for advanced germ cell tumor in the last decade].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cis | 2010 |
Unusual seminoma revealed by bone metastasis.
Topics: Bone Neoplasms; Cisplatin; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Magnetic Resona | 2011 |
Radically resected epithelioid angiosarcoma that originated in the mediastinum.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemotherapy, Adjuvant; Doxorubicin; | 2011 |
[A case of mediastinal angiosarcoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chest Pain; Doxorubicin; Dyspnea; Fema | 2012 |
Severe methotrexate toxicity due to a concomitant administration of ciprofloxacin.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Ant | 2013 |
Myelodysplastic syndrome (RARS) with +i(12p) abnormality in a patient 10 months after diagnosis and successful treatment of a mediastinal germ cell tumor (MGCT).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 12; Cisplatin; Etopo | 2004 |
Pericardial synovial sarcoma: 14-year survival with multimodality therapy.
Topics: Adult; Chemotherapy, Adjuvant; Dimethoate; Disease Progression; Doxorubicin; Drug Administration Sch | 2004 |
Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Disease-Free Survival; Et | 2004 |
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Etopo | 2005 |
Cure of a patient with profoundly chemotherapy-refractory primary mediastinal large B-cell lymphoma: role of rituximab, high-dose therapy, and allogeneic stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2005 |
[Yolk sac tumor of the anterior mediastinum and pulmonary metastases; report of a case].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Mod | 2005 |
[Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca | 2006 |
Metachronous intracranial germinoma in a patient with a previous primary mediastinal seminoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Combin | 2006 |
Recurrent superior mediastinal primary hemangiopericytoma 23 years after the complete initial excision: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Epirubicin; Fatal Outcome | 2006 |
Mediastinal follicular dendritic cell sarcoma involving bone marrow: a case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Dendritic Cells, Fol | 2006 |
[A case of CD56 positive T-cell lymphoma originating from mediastinal lymph nodes].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; CD56 Antigen; Cyclophosphamide; Dexamet | 2006 |
[Clinical analysis of primary mediastinal germ cell tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Comb | 2007 |
Mediastinal sarcoma with deviated tracheal anatomy.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Doxorubicin; Female; Humans; Ifosfam | 2008 |
Metastatic malignant teratoma arising from mediastinal nonseminomatous germ cell tumor: a case report.
Topics: Adult; Dacarbazine; Doxorubicin; Fatal Outcome; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; | 2008 |
Effects of intensive induction chemotherapy for extensive-disease small cell bronchogenic carcinoma in protected environment-prophylactic antibiotic units.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carcinoma, Bronch | 1984 |
[Spontaneous pneumothorax in response to chemotherapy of metastatic germinal tumor].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Etopos | 1995 |
Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Carcinoma | 1995 |
Primary extracranial rhabdoid tumors. Clinicopathologic features and response to ifosfamide.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Chil | 1993 |
True histiocytic lymphoma following therapy for lymphoblastic neoplasms.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Neoplasms; Child; Cisplati | 1996 |
Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etopo | 1996 |
High-dose chemotherapy in germ cell tumours: a large single centre experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Surviva | 1998 |
[High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin | 1999 |
Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Humans; Ifosfamide; Male; Me | 1999 |
Chemotherapy in patients with metastatic or relapsed germ-cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Etop | 2001 |
Salvage therapy with high-dose chemotherapy and autologous bone marrow support in the treatment of primary nonseminomatous mediastinal germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cis | 1991 |
VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Female; Humans; Ifosfami | 1986 |